Jaume Mateu

Q: What is Jaume Mateu email address?

Email Jaume Mateu at jaume.mateu@novartis.com. This email is the most updated Jaume Mateu's email found in 2026.

Q: How to contact Jaume Mateu?

To contact Jaume Mateu send an email to jaume.mateu@novartis.com.

Senior Machine Learning Engineer at Prima | Greater Palma de Mallorca Metropolitan Area

About Jaume Mateu

Jaume Mateu is a seasoned Senior Software Developer at the Novartis Digital Finance Hub in Barcelona, where he plays a pivotal role in advancing the integration of Machine Learning solutions within the pharmaceutical sector. With a robust background in software development since 2019, Jaume specializes in designing and implementing sophisticated Machine Learning pipelines that enhance data-driven decision-making processes. His current role involves not only the technical development of these solutions but also the strategic oversight of various projects that bring together small, agile teams of software developers, data scientists, and cloud infrastructure engineers.

At Novartis, Jaume is instrumental in aligning the diverse efforts of these technical teams to ensure that projects are executed efficiently and effectively. He employs his expertise in Python programming and Docker containerization to build scalable and maintainable applications that can handle complex financial data analytics. His collaborative approach fosters an environment where innovative ideas can flourish, enabling the team to tackle challenging problems and deliver high-quality solutions on time.

Key projects under Jaume's leadership include the development of predictive analytics tools that optimize financial forecasting and resource allocation within the organization. By leveraging advanced Machine Learning techniques, he is helping to transform how Novartis approaches financial modeling and analysis, ultimately driving better business outcomes. Jaume’s commitment to continuous learning and improvement ensures that he stays at the forefront of technological advancements, making him a valuable asset to Novartis and the broader healthcare technology landscape.

Jaume Mateu Work